Hadrian Szpurka is a versatile professional with a strong background in clinical diagnostics and business development. With extensive experience in deal negotiation and implementation, Hadrian has successfully led various teams and projects. Their expertise in developing biomarker assays and supporting oncology clinical trials showcases their commitment to advancing healthcare. Szpurka's academic achievements include a PhD in translational hematology and hematopoiesis, alongside an MBA in Finance, reflecting their dedication to both scientific research and business acumen.
View in org chart
View in org chart
March 1, 2024 - present
December, 2023